The Role of Dual-Time Combined 18-Fluorideoxyglucose Positron Emission Tomography and Computed Tomography in the Staging and Restaging Workup of Locally Advanced Rectal Cancer, Treated With Preoperative Chemoradiation Therapy and Radical Surgery

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 5, 2009, Pages 1461-1469

  Capirci, Carlo ^a   Rubello, Domenico ^a   Pasini, Felice ^a   Galeotti, Fabrizio ^a   Bianchini, Enzo ^a   Del Favero, Giuseppe ^a   Panzavolta, Riccardo ^a   Crepaldi, Giorgio ^a   Rampin, Lucia ^a   Facci, Enzo ^a   Gava, Marcello ^a   Banti, Elena ^a   Marano, Gianfranco ^a  

^a State Hospital   (Italy)

Author keywords

Chemoradiation; Pathologic response; PET; Rectal cancer

Indexed keywords

ANTI-TUMOR; CHEMORADIATION; COMPUTED TOMOGRAPHY; CUT-OFF; DUAL TIME; FDG-PET; FLUORINE-18; FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHIES; NEGATIVE PREDICTIVE VALUE; PATHOLOGIC RESPONSE; PET; POSITIVE PREDICTIVE VALUES; PREOPERATIVE CHEMORADIATION; RADIATION THERAPY; RADICAL SURGERY; RECTAL CANCER; RESPONSE INDICES;

CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; FLUORESCENT SCREENS; FLUORINE; POSITRONS; RADIOISOTOPES; RADIOTHERAPY; SURGERY; TELEVISION PICTURE TUBES;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG DOSE REDUCTION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; FEMALE; FLUORODEOXYGLUCOSE F18; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS; REMISSION INDUCTION; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67651109072     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.10.064     Document Type: Article

References (36)

1. Gerard J.P., Conroy T., Bonnetain F., et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24 (2006) 4620-4625
2. Bosset J.F., Collette L., Calais G., et al. EORTC Radiotherapy Group Trial 22921. Chemotherapy with pre-operative radiotherapy in rectal cancer. N Engl J Med 355 (2006) 1114-1123
3. Valentini V., Coco C., and Cellini N. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer. Acute toxicity, tumor response and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys 51 (2001) 371-383
4. Medical Research Council Rectal Cancer Working Party. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Lancet 348 (1996) 1605-1610
5. Bipat S., Glas A.S., Slors F.J., et al. Rectal cancer: Local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging-a meta analysis. Radiology 232 (2004) 773-783
6. Hoffmann K.T., Rau B., and Wust P. Restaging of locally advanced carcinoma of the rectum with MR imaging after preoperative radio-chemotherapy plus regional hyperthermia. Strahlenther Onkol 178 (2002) 386-392
7. Capirci C., Rampin L., Erba P.A., et al. Sequential FDG-PET/CT reliability predicts response of locally advanced rectal cancer to neoadjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging 34 (2007) 1583-1593
8. Kalff V., Duong C., Drummond E.G., et al. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery. J Nucl Med 47 (2006) 14-22
9. Vecchio F.M., Valentini V., and Minsky B.D. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 62 (2005) 752-760
10. Mandard A.M., Dalibard F., Mandard J.C., et al. Pathologic assessment of tumor regression after preoperative CRT of esophageal carcinoma. Clinicopathologic correlations. Cancer 73 (1994) 2680-2686
11. 18F]FDG PET in patients with locally advanced rectal cancer treated with neo-adjuvant radiochemotherapy. Am J Roengtenol 187 (2006) W202-W208
12. Capirci C., Valentini V., Cionini L., et al. Prognostic value of pathological complete response after neoadjuvant therapy in locally advanced rectal cancer: Long term analysis on 566 ypCR patients. [Epub ahead of print, April 11]. Int J Radiat Oncol Biol Phys (2008)
13. Gearhart S.L., Frassica D., Rosen R., et al. Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer. Ann Sur Oncol 13 (2006) 397-404
14. Tateishi U., Maeda T., Morimoto T., et al. Non-enhanced CT versus contrast-enhanced CT in integrated PET/CT studies for nodal staging rectal cancer. Eur J Nucl Med Mol Imaging 34 (2007) 1627-1634
15. Bar-Shalom R., Yefremov N., Guralnik L., et al. Clinical performance of PET/CT in evaluation of cancer: Additional value for diagnostic imaging and patient management. J Nucl Med 44 (2003) 1200-1209
16. Park I.J., Kim H.C., Yu C.S., et al. Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma. Eur J Surg Oncol 32 (2006) 941-947
17. Heriot A.G., Hicks R.J., Drummond E.G., et al. Does positron emission tomography change management in primary rectal cancer? A prospective assessment. Dis Colon Rectum 47 (2004) 451-458
18. Capirci C., Valvo F., and Salviato S. Concurrent boost radiotherapy as preoperative treatment for locally advanced rectal carcinoma: A new beam arrangement. Tumori 88 (2002) 325-330
19. Capirci C., Polico C., and Mandoliti G. Dislocation of small bowel volume within box pelvic treatment fields, using the new "up down table" device. Int J Radiat Oncol Biol Phys 88 (2002) 325-330
20. Quirke P., and Dixon M.F. The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis 3 (1988) 127-131
21. Mohiuddin M., Regine W.F., Marks J., et al. High-dose preoperative radiation and the challenge of a sphincter-preservation surgery for cancer of the distal 2 cm of the rectum. Int J Radiat Oncol Biol Phys 40 (1998) 569-574
22. Deneke T., Rau B., and Hoffmann K.T. Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging?. Eur Radiol 15 (2005) 1658-1666
23. Amthauer H., Deneke T., and Rau B. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined hyperthermia of rectal cancer: Correlation with endorectal ultrasound and histopathology. Eur J Nucl Med Mol Imaging 31 (2004) 811-819
24. Cascini G.L., Avallone A., Delrio P., et al. 18F-FDG PET is an early predictor of pathologic tumour response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 47 (2006) 1241-1248
25. Mamede M., El Fakhri G., Abreu-e-Lima P., et al. Pre-operative estimation of esophageal tumour metabolic length in FDG-PET images with surgical pathology confirmation. Ann Nucl Med 10 (2007) 553-562
26. Di Fabio F., Pinto C., and Ceccarelli C. Correlation between FDG-PET and pathologic response in patients with rectal cancer treated with neoadjuvant chemo-radiotherapy: First results of the Bologna Project. ASCO (2005) Abs. n. 3623
27. 11C]methyl-L-methionine for therapy monitoring in patients with rectal cancer. Eur J Nucl Med Mol Imaging 29 (2002) 789-796
28. Oku S., Nakagawa K., and Momose T. FDG-PET after radiotherapy is a good prognostic indicator of rectal cancer. Ann Nucl Med 16 (2002) 409-416
29. Calvo F.A., Domper M., and Matute R. 18FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 58 (2004) 528-535
30. Guillem J.G., Moore T., and Akhurst T. Sequential FDG-PET imaging for detecting subclinical rectal cancer response to preoperative combined modality therapy. J Am Coll Surg 199 (2004) 1-7
31. Komski A., Hoffman J., Sigurdson E., et al. Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Center prospective experience. Semin Oncol 32 Suppl. 9 (2005) S63-S67
32. Wieder H.A., Geinitz H., Rosenberg R., et al. PET imaging with [(18)F]3′-deoxy-3′-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer. Eur J Nucl Med Mol Imaging 34 (2007) 878-883
33. Melton G.B., Lavely W.C., Jacene H.A., et al. Efficacy of preoperative combined 18-fluorideoxyglucose positron emission tomography and computer tomography for assessing primary rectal cancer response to neoadjuvant therapy. J Gastrointest Surg 11 (2007) 961-969
34. Weber W.A., Ziegler S.I., Thodtmann R., et al. Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med 40 (1999) 1771-1777
35. Capirci C., Rubello D., Chierichetti F., et al. Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: Role of F18-FDG PET. Biomed Pharmacol 58 (2004) 451-457
36. Chessin B.D., Akhurst T., and Yeung H. Positron emission tomography during preoperative combined modality therapy for rectal cancer may predict ultimate pathologic response: A prospective analysis. ASCO Annual Meeting Proceedings. J Clin Oncol 16 (2005) 3612